Assessing a prostate cancer brachytherapy technique using early patient-reported symptoms: A potential early indicator for technology assessment?

Clinical Prostate Cancer

Volumn 3, Issue 1, 2004, Pages 38-42

  Seo, Pearl H ^a   D'Amico, Anthony V ^b,f   Clark, Jack A ^c   Kaplan, Irving ^d,f   Manola, Judith B ^e   Mitchell, Sonya P ^a   Talcott, James A ^a,f  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^e DANA FARBER CANCER INSTITUTE   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Bowel dysfunction; Quality of life; Sexual function; Treatment outcomes; Urinary incontinence

Indexed keywords

ADULT; AGED; ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; BRACHYTHERAPY; CONTROLLED STUDY; EARLY CANCER; ECHOGRAPHY; ENTEROPATHY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PROSTATE CANCER; RADIATION INJURY; SELF REPORT; SEXUAL DYSFUNCTION; TREATMENT OUTCOME; URINARY TRACT OBSTRUCTION; URINE INCONTINENCE;

EID: 3442893254     PISSN: 15400352     EISSN: None     Source Type: Journal    
DOI: 10.3816/CGC.2004.n.011     Document Type: Article

References (21)

1. American Cancer Society. Cancer Facts & Figures 2004, Atlanta, GA: ACS, 2004.
2. Litwin M. Health-related quality of life after treatment for localized prostate cancer. Cancer 1995; 75:2000-2003.
3. Talcott JA, Rieker P, Clark JA, et al. Patient-reported symptoms after primary therapy for early prostate cancer: results of a prospective cohort study. J Clin Oncol 1998; 16:275-283.
4. D'Amico AV, Coleman CN. Role of interstitial radiotherapy in the management of clinically organ-confined prostate cancer: the jury is still out. J Clin Oncol 1996; 14:304-315.
5. Sylvester J, Blasko JC, Grimm P, et al. Interstitial implantation techniques in prostate cancer. J Surg Oncol 1997; 66:65-75.
6. Stock RG, Stone NN, Iannuzzi C. Sexual potency following interactive ultrasound-guided brachytherapy for prostate cancer. Int J Radiat Oncol Biol Phys 1996; 35:267-272.
7. Blasko JC, Grimm PD, Ragde H. Brachytherapy and organ preservation in the management of carcinoma of the prostate. Sem Rad Oncol 1993; 3:240-249.
8. Wallner K, Roy J, Harrison L. Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma. J Clin Oncol 1996; 14:449-453.
9. Zelefsky MJ, Wallner KE, Ling CC, et al. Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer. J Clin Oncol 1999; 17:517-522.
10. Talcott JA, Clark JA, Stark PC, et al. Long-term treatment related complications of brachytherapy for early prostate cancer: a survey of patients previously treated. J Urol 2001; 166:494-499.
11. Talcott JA, Manola J, Clark JA, et al. Time course and predictors of symptoms after primary prostate cancer therapy. J Clin Oncol 2003; 21:3979-3986.
12. Wallner K, Roy J, Harrison L. Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy. Int J Radiat Oncol Biol Phys 1995; 32:465-471.
13. D'Amico AV, Cormack R, Tempany CM, et al. Real-time magnetic resonance image-guided interstitial brachytherapy in the treatment of select patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 1998; 42:507-515.
14. Prete JJ, Prestidge BR, Bice WS, et al. Comparison of MRI- and CT-based post-implant dosimetric analysis of transperineal interstitial permanent prostate brachytherapy. Radiat Oncol Investig 1998; 6:90-96.
15. Clark JA, Talcott JA. Symptom indexes to assess outcomes of treatment for early prostate cancer. Med Care 2001; 39:1118-1130.
16. Han BH, Wallner KE. Dosimetric and radiographic correlates to prostate brachytherapy-related rectal complications. Int J Cancer 2001; 96:372-378.
17. Walsh PC, Lepor H, Eggleston JC. Radical prostatectomy with preservation of sexual function: anatomical and pathological considerations. Prostate 1983; 4:473-485.
18. Davis JW, Kuban DA, Lynch DF, et al. Quality of life after treatment for localized prostate cancer: differences based on treatment modality. J Urol 2001; 166:947-952.
19. Lee WR, McQuellon RP, McCullough DL. A prospective analysis of patient-reported quality of life after prostate brachytherapy. Semin Urol Oncol 2000; 18:147-151.
20. Wei JT, Dunn RL, Sandler HM, et al. Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer. J Clin Oncol 2002; 20:557-566.
21. Wallner K, Merrick G, True L, et al. 1-125 versus Pd-103 for low-risk prostate cancer: morbidity outcomes from a prospective randomized multicenter trial. Cancer J 2002; 8:67-73.